Still, I expect as is generally the case, real-world effectiveness will be substantially lower than clinical efficacy
Weight loss above 15%, seen with Novos Wegovy (at 68 weeks), is the minimum bar
This conversation is particularly important for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), as these represent absolute contraindications to the use of products with the thyroid C-cell tumor boxed warning, including semaglutide, liraglutide, dulaglutide, exenatide extended-release, and tirzepatide
Resolvins and protectins, which are anti-inflammatory mediators, are subsequently produced because of this event (166)
Neurologic aspects of cobalamin (B12) deficiency
Aim for 0.7-1 gram of protein per pound of body weight to preserve muscle mass during weight loss